Knee Arthritis: Clinical Trials

89 trials for Knee Arthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 completed, 17 unknown, 6 terminated, 5 active not recruiting. 39 Not applicable, 14 Phase 4, 6 Phase 2, 6 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable39Completed 22, Unknown 8, Active not recruiting 3, Not yet recruiting 2, Withdrawn 2, Recruiting 1, Terminated 1
Phase 414Completed 11, Not yet recruiting 2, Unknown 1
Phase 26Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 36Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 11Completed 1

Follow Knee Arthritis: new trials by email Literature Review of Knee Arthritis trials Research Report on Knee Arthritis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis
Phase 2 / Phase 3Not yet recruitingGenascence Corporation2402027-07-012026-09-21
Role of Suzetrigine as a Part of a Multimodal Regimen to Reduce Pain and Opioid Use After Total Knee Arthroplasty
Suzetrigine - Knee Arthritis, Knee Osteoarthritis
Phase 4Not yet recruitingEmory University752026-07-012026-06-03
Implant-Related Infections in Patients With Skeletal Sarcomas
Implant Infection, Skeletal Sarcoma
Enrolling by invitationVastra Gotaland Region402025-02-052025-12-04
Genicular Artery Embolization (GAE) for Osteoarthritic Knee Pain
Genicular artery embolization (GAE) - Knee Osteoarthritis, Knee Pain Chronic
Not applicableWithdrawnAndrew Picel2025-01-152025-02-24
Two-level ESPB in Total Knee Arthroplasty
2 x 20 ml of Ropivacaine 0.2% Injectable Solution, 2 x 20ml of Ropivacaine 0.2% Injectable Solution - Knee Osteoarthritis, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences602024-11-072025-11-25
Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement
Bupivacaine liposome, Nerve block mode : adductor block, Bupivacaine - Knee Arthropathy, Knee Arthritis
Phase 4Not yet recruitingHuazhong University of Science and Technology1442024-11-052024-10-24
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty
0.9% Sodium Chloride Injection, Dexamethasone, Dexmedetomidine - Knee Osteoarthritis, Knee Arthritis
Phase 4CompletedPoznan University of Medical Sciences902024-08-132026-03-30
Dexamethasone for iPACK Block With ACB in Total Knee Arthroplasty
Ropivacaine, Ropivacaine+Dexamethasone - Knee Osteoarthritis, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences602024-08-132025-07-23
Non-Invasive Distractor During Knee Arthroscopy
Non-Invasive Knee Joint Distraction, Manual Joint Distraction - Knee Arthritis, Knee Arthropathy
Not applicableUnknownThe Taylor Collaboration142024-06-012024-06-14
Comparison of Two Robotic-Assisted Total Knee Arthroplasty Systems
Stryker Triathlon with MAKO Robotic-Arm, DePuy Attune with VELYS Robotic-Assistance - Knee Osteoarthritis, Knee Arthritis
Not applicableNot yet recruitingSoutheast Orthopedic Specialists1202024-05-012024-04-17
ESPB vs iPACK+ACB in Total Knee Arthroplasty
Ropivacaine 0.2% Injectable Solution, control group - Knee Arthritis, Knee Arthropathy
Phase 4UnknownPoznan University of Medical Sciences602024-04-012024-03-08
Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty
Control Test - spinal anesthesia, Ropivacaine 0.2% Injectable Solution ESPB, Ropivacaine 0.2% Injectable Solution iPACK+ACB - Knee Osteoarthritis, Knee Pain Chronic
Phase 4CompletedPoznan University of Medical Sciences902024-03-302024-09-26
Persona IQ Cohort Study
Persona IQ - Osteo Arthritis Knee, Knee Arthritis
Active not recruitingZimmer Biomet2002024-02-202026-06-04
The Roles of MRI, DYNEELAX and Stress X-ray in First-Line Diagnosis of Cruciate Ligament Injury
knee stability test (DYNEELAX) - Knee Injuries, Anterior Cruciate Ligament Injuries
UnknownKaohsiung Veterans General Hospital.502024-01-012024-02-14
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
JOINTSTEM - Degenerative Arthritis, Knee Arthritis
Not applicableNot yet recruitingR-Bio142023-12-012022-09-28
Methylprednisolone Taper After Total Knee Replacement
Methylprednisolone, Standard of Care - Knee Arthritis
Phase 4CompletedEmory University1012023-10-162025-09-18
The Effect of PPB Using 10, 20 and 30 ml of Lidocaine, Study on Volunteers
Popliteal Plexus Block with 10 ml, Popliteal Plexus Block with 20 ml, Popliteal Plexus Block with 30 ml - Knee Arthritis, Anesthesia, Local
Phase 4CompletedCharlotte Runge402023-09-292024-04-11
Maximal Rate of Force Development of Ankle Muscles and Functional Ability in Patients With Knee Osteoarthritis
Maximal Rate of Force Development Test for Ankle Muscles - Knee Osteoarthritis, Knee Arthritis
CompletedAhram Canadian University1262023-07-202024-08-06
QIST Collaborative - Arthroplasty Research Cohort (ARC) Study
Hip/Knee Replacement - Hip Arthritis, Knee Arthritis
RecruitingNorthumbria Healthcare NHS Foundation Trust50002023-07-132024-11-18
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
JOINTSTEM, Saline - Degenerative Arthritis, Knee Arthritis
Not applicableUnknownR-Bio212023-07-012022-09-28

Showing 20 of 89. Sign in to see all of them.

Narrower conditions

Osteoarthritis, Knee (41)  ·  Osteoarthritis (16)  ·  Knee Injuries (6)  ·  Arthritis (4)  ·  Arthritis, Rheumatoid (4)  ·  Pain (4)  ·  Obesity (2)  ·  Osteoarthritis, Hip (2)  ·  Acute Pain (1)  ·  Agnosia (1)  ·  Anterior Cruciate Ligament Injuries (1)  ·  Arterial Occlusive Diseases (1)  ·  Arthralgia (1)  ·  Arthritis, Gouty (1)  ·  Arthritis, Infectious (1)

Broader conditions

Musculoskeletal Diseases (51)  ·  Joint Diseases (50)  ·  Rheumatic Diseases (48)  ·  Arthritis (47)  ·  Osteoarthritis (32)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Signs and Symptoms (12)  ·  Neurologic Manifestations (10)  ·  Wounds and Injuries (8)  ·  Leg Injuries (7)  ·  Nervous System Diseases (5)  ·  Pathologic Processes (5)  ·  Autoimmune Diseases (4)  ·  Connective Tissue Diseases (4)  ·  Immune System Diseases (4)

Interventions

Ropivacaine (5)  ·  Sodium Chloride (5)  ·  Arthroplasty, Replacement, Knee (3)  ·  Anesthesia, Spinal (2)  ·  Control Groups (2)  ·  Saline Solution (2)  ·  Aminocaproic Acid (1)  ·  Arthroplasty (1)  ·  Ascorbic Acid (1)  ·  Biomechanical Phenomena (1)  ·  Bupivacaine (1)  ·  Cannabidiol (1)  ·  Cholecalciferol (1)  ·  Dexamethasone (1)  ·  Dexmedetomidine (1)

Sponsors

Poznan University of Medical Sciences (6)  ·  Zimmer Biomet (3)  ·  Aksaray University Training and Research Hospital (2)  ·  Bezmialem Vakif University (2)  ·  Biomet Orthopedics, LLC (2)  ·  Duke University (2)  ·  Emory University (2)  ·  Medical University of Warsaw (2)  ·  Ottawa Hospital Research Institute (2)  ·  R-Bio (2)  ·  4Life Research, LLC (1)  ·  ASST Gaetano Pini-CTO (1)  ·  Acibadem University (1)  ·  Aesculap AG (1)  ·  Ahram Canadian University (1)

Countries

United States (27)  ·  Poland (9)  ·  Turkey (Türkiye) (7)  ·  France (6)  ·  Canada (4)  ·  China (4)  ·  United Kingdom (4)  ·  Egypt (3)  ·  Italy (3)  ·  Denmark (2)  ·  Germany (2)  ·  Taiwan (2)  ·  Croatia (1)  ·  Russia (1)  ·  Saudi Arabia (1)

Top investigators

Ajay Premkumar, MD (2)  ·  Malgorzata Domagalska, Ph.D. (2)  ·  Malgorzata Reysner, M.D. Ph.D. (2)  ·  Simon Garceau, MD (2)  ·  Abeer Abdelrahman, Ph.D (1)  ·  Adam Freedhand, MD (1)  ·  Ana M Valdes, PhD (1)  ·  Andrew C Picel, MD (1)  ·  Andrew Price, FRCS PhD (1)  ·  Annabelle Visperas, BS (1)  ·  Artur Stolarczyk, PhD (1)  ·  Bradley Myers, PT, DPT, DSc (1)

Results publications

PMID 28770628, PMID 29910837, PMID 31218390, PMID 32385824, PMID 32434498, PMID 33151364, PMID 34431329, PMID 37491199, PMID 37678215, PMID 38127974, PMID 40185510, PMID 41902932

NIH funding

2023 (1)